Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study by Audrey Giocanti-Aurégan, Simone Donati, Hans Hoerauf, Helmut Allmeier, Kay D. Rittenhouse, Tobias Machewitz, Chang-Hao Yang, On behalf of the AURIGA Study Investigators

Get full text

XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration by Jean-François Korobelnik, Varun Chaudhary, Paul Mitchell, Se Woong Kang, Ramin Tadayoni, Helmut Allmeier, JinKyung Lee, Xin Zhang, Tobias Machewitz, Clare Bailey

Get full text

Intravitreal aflibercept for the treatment of patients with diabetic macular edema in routine clinical practice in Latin America: the AQUILA study by Francisco J. Rodríguez, Lihteh Wu, Arnaldo F. Bordon, Martin Charles, JinKyung Lee, Tobias Machewitz, Margarete Mueller, Gabriela del Carmen Gay, Jans Fromow-Guerra, the AQUILA Investigators

Get full text

Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study by Simone Donati, Chang-Hao Yang, Xun Xu, Marco Mura, Audrey Giocanti-Aurégan, Hans Hoerauf, Helmut Allmeier, Tobias Machewitz, Kristian T. Johnson, Elina Santoro, On behalf of the AURIGA study investigators

Get full text

Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study by Lihteh Wu, Arnaldo F. Bordon, Martin Charles, Francisco J. Rodríguez, JinKyung Lee, Tobias Machewitz, Margarete Mueller, Gabriela del Carmen Gay, Jans Fromow-Guerra, the AQUILA investigators

Get full text